Protective effects of leukotriene receptor antagonists (LTRAs) in dementia and Alzheimer’s disease (AD)
Summary
Project ID: 2020-795/ TRIM 2022 0970 269 000
Principal Investigator: Walter Swardfager
Description: The purpose of this research is to determine if LTRAs, namely Montelukast and Zafirlukast, have a protective effect on the development of dementia and specifically, AD dementia in a cohort of Ontario residents aged 65+.
PIA approved: March 31, 2021
Status: In progress
Public Sector Project
2027
Understanding the Epidemiology and Service Needs of Co-occurring and Substance-Induced Mental Disorders (COSIMD) in Ontario
Project ID: 2026-1320/2027 0970 442 000
Project Year: 2027
Status: In progress
Public Sector Project
2027
Social Participation, Well-Being, and Healthcare Utilization: Examining the Engagement with and Benefits of Social Participation in Ontario
Project ID: 2025-1307-2027 0970 448 000
Project Year: 2027
Status: In progress